The health care delivery system continues to evolve to provide ever-enhanced value to patients. This requires a shift in regulatory science, tools, realities, and perceptions of biopharmaceutical product benefit-risk across the global pharmacovigilance landscape. It is more important than ever to find ways to fully harness innovation and adopt new technologies to advance pharmacovigilance practices. During this three-day meeting, thought leaders from around the world will provide their insights and engage in dialogue on current and potential new opportunities, operational challenges, and practical aspects, as well as demands in managing product risk in the context of benefits, in the ever-changing world of medical product safety, pharmacovigilance, and global regulations.
This event will provide an unique opportunity for dialogue with representatives from FDA and other key regulatory agencies, as well as from industry and academia. There will be multiple opportunities for participants to engage with speakers and interact with colleagues.
Conference Highlights:
- Global Regulatory Safety Updates
- New Data Sources for Safety Assessment
- Current Approaches to Benefit-Risk Assessment
- Luncheon Roundtable Discussions with Key Thought Leaders
- Tabletop Exhibits and Networking Opportunities
- Tutorial Offerings on Sunday, January 24
